المؤلفون: Wang H; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 450008, Zhengzhou, China., Hou J; Department of Oncology, The Second People's Hospital of Jiaozuo, 454000, Jiaozuo, China., Zhang G; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 450008, Zhengzhou, China., Zhang M; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 450008, Zhengzhou, China., Li P; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 450008, Zhengzhou, China., Yan X; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 450008, Zhengzhou, China., Ma Z; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 450008, Zhengzhou, China. 18638529152@163.com.

المصدر: Cancer gene therapy [Cancer Gene Ther] 2019 Nov; Vol. 26 (11-12), pp. 419-426. Date of Electronic Publication: 2019 Jan 31.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5500 (Electronic) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms/*epidemiology , Neoplasms, Multiple Primary/*epidemiology, Age of Onset ; Aged ; Female ; Humans ; Lung Neoplasms/diagnosis ; Lung Neoplasms/mortality ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Staging ; Neoplasms, Multiple Primary/diagnosis ; Neoplasms, Multiple Primary/etiology ; Neoplasms, Multiple Primary/mortality ; Prognosis ; Proportional Hazards Models ; Public Health Surveillance